Literature DB >> 15855104

MR quantification of the washout changes in breast tumors under preoperative chemotherapy: feasibility and preliminary results.

Carl El Khoury1, Vincent Servois, Fabienne Thibault, Anne Tardivon, Lilianne Ollivier, Martine Meunier, Caroline Allonier, Sylvia Neuenschwander.   

Abstract

OBJECTIVE: The objective of our study was to describe and determine the feasibility of an MR washout quantification method in patients with breast cancer under preoperative chemotherapy.
MATERIALS AND METHODS: Nineteen patients with breast T2 or T3 tumors were enrolled in a previous study for tumor response evaluation during chemotherapy based on dynamic contrast-enhanced MRI. We retrospectively used the dynamic acquisition data to produce parametric images representing the washout pattern. Two radiologists unaware of the final pathologic results measured the volume of pixels exhibiting washout within the tumor before chemotherapy (volume 1), after two courses of chemotherapy (volume 2), and before surgery after four courses of chemotherapy (volume 3). The interobserver variability and intraobserver variability were calculated to evaluate the reproducibility of our method with the Pearson's correlation coefficient and the concordance correlation coefficient. We correlated the washout changes by means of a Student's t test and noted the histopathologic final outcome.
RESULTS: A washout pattern was present in all patients on the initial MR study. The quantification method of the washout changes was reproducible with good interobserver agreement (r = 0.85, p < 10(-5)) and an excellent intraobserver agreement (r = 0.94, p < 10(-5)). A significant decrease of the washout volume was observed after two courses of chemotherapy (p = 0.004), whereas no significant modification was observed between two and four courses of chemotherapy (p = 0.52).
CONCLUSION: Quantification of the washout variation in breast tumor based on the use of parametric images is feasible and reproducible. It may add information to the evaluation of tumor response to preoperative therapy.

Entities:  

Mesh:

Year:  2005        PMID: 15855104     DOI: 10.2214/ajr.184.5.01841499

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  Evaluation of Neoadjuvant Chemotherapy Response with Dynamic Contrast Enhanced Breast Magnetic Resonance Imaging in Locally Advanced Invasive Breast Cancer.

Authors:  Naciye Sinem Gezer; Özge Orbay; Pınar Balcı; Merih Guray Durak; Binnaz Demirkan; Serdar Saydam
Journal:  J Breast Health       Date:  2014-04-01

2.  Early assessment of breast cancer response to neoadjuvant chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI: preliminary results.

Authors:  Richard G Abramson; Xia Li; Tamarya Lea Hoyt; Pei-Fang Su; Lori R Arlinghaus; Kevin J Wilson; Vandana G Abramson; A Bapsi Chakravarthy; Thomas E Yankeelov
Journal:  Magn Reson Imaging       Date:  2013-08-15       Impact factor: 2.546

Review 3.  MRI in breast cancer therapy monitoring.

Authors:  Rebekah McLaughlin; Nola Hylton
Journal:  NMR Biomed       Date:  2011-06-21       Impact factor: 4.044

Review 4.  Monitoring therapeutic efficacy in breast carcinomas.

Authors:  Anne A Tardivon; Liliane Ollivier; Carl El Khoury; Fabienne Thibault
Journal:  Eur Radiol       Date:  2006-05-30       Impact factor: 7.034

5.  Accuracy of perfusion MRI with high spatial but low temporal resolution to assess invasive breast cancer response to neoadjuvant chemotherapy: a retrospective study.

Authors:  Cédric de Bazelaire; Raphael Calmon; Isabelle Thomassin; Clément Brunon; Anne-Sophie Hamy; Laure Fournier; Daniel Balvay; Marc Espié; Nathalie Siauve; Olivier Clément; Eric de Kerviler; Charles-André Cuénod
Journal:  BMC Cancer       Date:  2011-08-19       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.